FF
FOLD

FourThought Financial’s Amicus Therapeutics FOLD Stock Holding History

FourThought Financial’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-118
Closed -$1K – 1516
2022
Q2 		$1K Hold
118
– – ﹤0.01% 1395
2022
Q1 		$1K Sell
118
-160
-58% -$1.5K ﹤0.01% 1394
2021
Q4 		$3K Sell
278
-262
-49% -$2.92K ﹤0.01% 1311
2021
Q3 		$5K Sell
540
-212
-28% -$2.17K ﹤0.01% 1225
2021
Q2 		$7K Sell
752
-808
-52% -$7.89K ﹤0.01% 1159
2021
Q1 		$15K Hold
1,560
– – ﹤0.01% 961
2020
Q4 		$36K Buy
+1,560
New +$31.9K 0.01% 741

Other funds holding FOLD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FourThought Financial's FOLD Position: Q3 2022 in Review

FourThought Financial sold out of Amicus Therapeutics (FOLD) in Q3 2022, closing a stake of 118 shares — an estimated $1K sold.

FourThought Financial first reported a position in FOLD in Q4 2020 and held it in 7 quarters. The position peaked at $36K in Q4 2020. 222 funds tracked by Wall St. Rank hold FOLD as of Q3 2022.

  • FourThought Financial reported no remaining Amicus Therapeutics position as of Q3 2022 after selling out during the quarter.
  • FourThought Financial sold 118 Amicus Therapeutics shares in Q3 2022, an estimated $1K.
  • FourThought Financial first reported a position in Amicus Therapeutics in Q4 2020 and held it in 7 quarters.
  • FourThought Financial's Amicus Therapeutics position peaked at $36K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.